Cooper Companies Inc (COO) Position Increased by Prudential Financial Inc.

Prudential Financial Inc. grew its holdings in shares of Cooper Companies Inc (NYSE:COO) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 54,452 shares of the medical device company’s stock after buying an additional 648 shares during the period. Prudential Financial Inc. owned 0.11% of Cooper Companies worth $13,858,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Vanguard Group Inc raised its position in Cooper Companies by 0.6% in the 3rd quarter. Vanguard Group Inc now owns 5,041,468 shares of the medical device company’s stock worth $1,397,243,000 after buying an additional 31,280 shares during the last quarter. FIL Ltd raised its position in Cooper Companies by 16.1% in the 3rd quarter. FIL Ltd now owns 815,901 shares of the medical device company’s stock worth $226,127,000 after buying an additional 113,054 shares during the last quarter. Bessemer Group Inc. raised its position in Cooper Companies by 0.8% in the 3rd quarter. Bessemer Group Inc. now owns 761,555 shares of the medical device company’s stock worth $211,064,000 after buying an additional 5,828 shares during the last quarter. Findlay Park Partners LLP raised its position in Cooper Companies by 225.0% in the 3rd quarter. Findlay Park Partners LLP now owns 738,824 shares of the medical device company’s stock worth $204,765,000 after buying an additional 511,518 shares during the last quarter. Finally, Putnam Investments LLC raised its position in Cooper Companies by 228.5% in the 3rd quarter. Putnam Investments LLC now owns 622,865 shares of the medical device company’s stock worth $172,627,000 after buying an additional 433,242 shares during the last quarter.

Get Cooper Companies alerts:

In other Cooper Companies news, Director Allan E. Rubenstein purchased 348 shares of Cooper Companies stock in a transaction dated Monday, December 10th. The stock was purchased at an average price of $241.59 per share, with a total value of $84,073.32. Following the transaction, the director now directly owns 4,524 shares of the company’s stock, valued at $1,092,953.16. The purchase was disclosed in a document filed with the SEC, which is available through this link. 1.70% of the stock is owned by corporate insiders.

COO has been the subject of a number of recent analyst reports. Wells Fargo & Co boosted their target price on Cooper Companies from $290.00 to $295.00 and gave the stock an “outperform” rating in a research report on Monday, November 12th. Goldman Sachs Group lowered Cooper Companies from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $233.00 to $221.00 in a research report on Friday, January 4th. William Blair reissued an “outperform” rating on shares of Cooper Companies in a research report on Saturday, January 12th. KeyCorp reissued a “buy” rating on shares of Cooper Companies in a research report on Sunday, December 9th. Finally, Oppenheimer set a $282.00 target price on Cooper Companies and gave the stock a “hold” rating in a research report on Friday, December 7th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $289.44.

NYSE COO opened at $290.67 on Monday. Cooper Companies Inc has a 52 week low of $216.47 and a 52 week high of $295.36. The stock has a market cap of $14.44 billion, a PE ratio of 25.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.88. The company has a quick ratio of 1.16, a current ratio of 2.03 and a debt-to-equity ratio of 0.60.

Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, December 6th. The medical device company reported $2.87 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.96 by ($0.09). Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The business had revenue of $651.50 million for the quarter, compared to analysts’ expectations of $645.25 million. During the same period in the previous year, the company earned $2.65 EPS. Cooper Companies’s revenue for the quarter was up 16.0% compared to the same quarter last year. Sell-side analysts forecast that Cooper Companies Inc will post 11.56 EPS for the current fiscal year.

The firm also recently declared a semiannual dividend, which was paid on Friday, February 8th. Stockholders of record on Tuesday, January 22nd were given a dividend of $0.03 per share. This represents a dividend yield of 0.02%. The ex-dividend date was Friday, January 18th. Cooper Companies’s payout ratio is currently 0.52%.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4196128/cooper-companies-inc-coo-position-increased-by-prudential-financial-inc.html.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: Special Dividends

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).